Dyax's IPO

Dyax raised a round of funding on August 15, 2000. Investors include Public.

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology to…

Articles about Dyax's IPO: